Vor Biopharma, Inc. (VOR)
22.71
-0.65
(-2.78%)
USD |
NASDAQ |
Aug 24, 16:00
22.71
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Total Assets (Quarterly) : 481.05M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 481.05M |
| March 31, 2026 | 506.75M |
| December 31, 2025 | 465.01M |
| September 30, 2025 | 176.24M |
| June 30, 2025 | 205.37M |
| March 31, 2025 | 109.31M |
| December 31, 2024 | 153.02M |
| September 30, 2024 | 115.99M |
| June 30, 2024 | 141.59M |
| March 31, 2024 | 167.03M |
| December 31, 2023 | 209.83M |
| September 30, 2023 | 223.02M |
| June 30, 2023 | 250.99M |
| March 31, 2023 | 277.53M |
| Date | Value |
|---|---|
| December 31, 2022 | 299.37M |
| September 30, 2022 | 206.37M |
| June 30, 2022 | 224.62M |
| March 31, 2022 | 234.27M |
| December 31, 2021 | 242.59M |
| September 30, 2021 | 258.63M |
| June 30, 2021 | 275.14M |
| March 31, 2021 | 292.94M |
| December 31, 2020 | 75.91M |
| September 30, 2020 | 88.52M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 9.826M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Dyne Therapeutics, Inc. | 994.01M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 681.25M |
| Shareholders Equity (Quarterly) | -200.20M |
| Debt to Equity Ratio | -0.0144 |
| Current Ratio | 19.15 |
| Net Debt Paydown Yield | 0.56% |